Rare Cancer News & Clinical Trials » Trial - Appendix Cancer » April 11, 2019

Feeds

38005 items (38005 unread) in 74 feeds

Acinar Cell Carcinoma (254 unread)

• Google - Acinar Cell Carcinoma (185 unread)
• PubMed - Acinar Cell Carcinoma (68 unread)
• Trial - Acinar Cell Carcinoma (1 unread)

Acinic Cell Carcinoma (166 unread)

• Google - Acinic Cell Carcinoma (83 unread)
• PubMed - Acinic Cell Carcinoma (83 unread)
• Trial - Acinic Cell Carcinoma

Adenoid Cystic Carcinoma (817 unread)

• Google - Adenoid Cystic Carcinoma (636 unread)
• PubMed - Adenoid Cystic Carcinoma (169 unread)
• Trial - Adenoid Cystic Carcinoma (12 unread)

Adrenal Gland Cancer (3132 unread)

• Google - Adrenal Cancer (1690 unread)
• Google - Adrenocortical Carcinoma (480 unread)
• PubMed - Adrenal Cancer (772 unread)
• PubMed - Adrenocortical Carcinoma (118 unread)
• Trial - Adrenal Cancer (63 unread)
• Trial - Adrenocortical Carcinoma (9 unread)

Ampulla Of Vater (1030 unread)

• Google - Ampullary Cancer (953 unread)
• PubMed - Ampullary Cancer (72 unread)
• Trial - Ampullary Carcinoma (5 unread)

Anal Cancer (3884 unread)

• Google - Anal Cancer (2357 unread)
• PubMed - Anal Cancer (1475 unread)
• Trial - Anal Cancers (52 unread)

Angiosarcoma (1204 unread)

• Google - Angiosarcoma (983 unread)
• PubMed - Angiosarcoma (212 unread)
• Trial - Angiosarcoma (9 unread)

Appendix Cancer (513 unread)

• Google - Appendix Cancer (333 unread)
• PubMed - Appendix Cancer (150 unread)
• Trial - Appendix Cancer (30 unread)

Bile Duct Cancer (4609 unread)

• Google - Bile Duct Cancer (1773 unread)
• Google - Cholangiocarcinoma (1153 unread)
• PubMed - Bile Duct Cancer (677 unread)
• PubMed - Cholangiocarcinoma (777 unread)
• Trial - Bile Duct Cancer (123 unread)
• Trial - Cholangiocarcinoma (106 unread)

Brain and CNS (5045 unread)

• Google - Rare Brain Tumor (2270 unread)
• Google - Rare CNS Tumor (945 unread)
• PubMed - Ganglioglioma (36 unread)
• PubMed - Rare Brain Tumor (553 unread)
• PubMed - Rare CNS Tumor (511 unread)
• Trial - Brain Tumor (417 unread)
• Trial - CNS Tumor (309 unread)
• Trial - Ganglioglioma (4 unread)

Carcinoid (1626 unread)

• Google - Carcinoid (1358 unread)
• PubMed - Carcinoid (258 unread)
• Trials - Carcinoid (10 unread)

Endocrine/Neuroendocrine (4250 unread)

• Google - Merkel Cell Cancer (1742 unread)
• Google - Neuroendocrine Tumor (1316 unread)
• PubMed - Merkel Cell Cancer (160 unread)
• PubMed - Neuroendocrine Tumor (731 unread)
• Trial - Merkel Cell Cancer (27 unread)
• Trial - Neuroendocrine Cancers (274 unread)

Gall Bladder Cancer (1710 unread)

• Google - Gall Bladder Cancer (1408 unread)
• PubMed - Gall Bladder Cancer (272 unread)
• Trials - Gall Bladder Cancer (30 unread)

Hemangioendothelioma (439 unread)

• Google - Hemangioendothelioma (346 unread)
• PubMed - Hemangioendothelioma (85 unread)
• Trial - Hemangioendothelioma (8 unread)

Hepatoblastoma (572 unread)

• Google - Hepatoblastoma (455 unread)
• PubMed - Hepatoblastoma (107 unread)
• Trial - Hepatoblastoma (10 unread)

Pancreas (513 unread)

• Google - Insulinoma (381 unread)
• PubMed - Insulinoma (126 unread)
• Trial - Insulinoma (6 unread)

Phyllodes (296 unread)

• Google - Phyllodes Tumor (239 unread)
• PubMed - Phyllodes Tumor (56 unread)
• Trial - Phyllodes (1 unread)

PMP and Mucinous Tumors (361 unread)

• Google - Pseudomyxoma Peritonei (309 unread)
• PubMed - Pseudomyxoma Peritonei (PMP) (49 unread)
• Trial - Pseudomyxoma Peritonei (3 unread)

Rhabdomyosarcoma (1388 unread)

• Google - Rhabdomyosarcoma (1110 unread)
• PubMed - Rhabdomyosarcoma (237 unread)
• Trial - Rhabdomyosarcoma (41 unread)

Sarcoma (6196 unread)

• Google - Sarcoma (2662 unread)
• PubMed - Sarcoma (3182 unread)
• Trial - Sarcoma (352 unread)

Trial - Appendix Cancer (1 unread)

• 

  A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT

  Posted: April 11th, 2019, 2:00pm GMT

  Conditions:   Acute Myeloid Leukemia;   Myelodysplastic Syndromes;   Myeloproliferative Neoplasms;   Chronic Myelomonocytic Leukemia;   Myelofibrosis
  Interventions:   Drug: Ipilimumab;   Biological: CD25hi Treg depleted DLI
  Sponsor:   Dana-Farber Cancer Institute
  Recruiting